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INTRODUCTION
Worldwide the population of those aged 
>65 years is growing faster than any other 
age group.1 The burden of cancer falls 
predominantly on older patients, with half 
of all new diagnoses occurring in people 
aged >70 years and incidence rates for 
all cancers increasing most rapidly in the 
>75 years age group.1,2 The benefits of 
asymptomatic cancer screening in older 
adults are unproven and, in most countries, 
it is not recommended.3,4 In countries such 
as the UK, symptomatic presentation to 
primary care is the most frequent route to a 
cancer diagnosis in older adults.5
Diagnosing cancer at an early stage is 
important, and associated with improved 
survival.6 In older adults, these survival 
benefits are likely to be reduced because 
of shorter life expectancy. If cancer is 
diagnosed, older patients who are frail have 
an increased risk of morbidity and mortality 
from cancer surgery, and intolerance to 
chemotherapy and radiotherapy.7 As a 
result, the management of older adults 
with cancer symptoms in primary care is 
difficult.8,9 Older adults need a balanced 
approach to the diagnosis and management 
of cancer symptoms. The imperative to 
diagnose cancer early in older adults must 
be balanced against the prognosis of the 
cancer, the likely success and tolerance of 
treatment, the presence of comorbidities, 
and patient preferences. Some older adults 
favour quality rather than length of life,10 
are less likely to want investigation for 
cancer symptoms, and would accept a 
higher risk of cancer being undiagnosed.11 
The aim of this review is to consider the 
global literature on the association between 
old age and the diagnostic process for 
cancer. The objectives were:
• to explore the effect of increasing age 
on the primary care interval (the time 
from first presentation to referral) in the 
diagnosis of cancer;
• to identify the factors that influence the 
decision to investigate potential cancer 
symptoms in older adults in primary 
care, both from a patient and healthcare 
professional perspective; and
• to understand how the factors identified 
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Abstract
Background
Older age and frailty increase the risk of 
morbidity and mortality from cancer surgery 
and intolerance of chemotherapy and 
radiotherapy. The effect of old age on diagnostic 
intervals is unknown; however, older adults 
need a balanced approach to the diagnosis 
and management of cancer symptoms, 
considering the benefits of early diagnosis, 
patient preferences, and the likely prognosis of 
a cancer.
Aim
To examine the association between older age 
and diagnostic processes for cancer, and the 
specific factors that affect diagnosis. 
Design and setting
A systematic literature review.
Method
Electronic databases were searched for studies 
of patients aged >65 years presenting with 
cancer symptoms to primary care considering 
diagnostic decisions. Studies were analysed 
using thematic synthesis and according to the 
Synthesis Without Meta-analysis guidelines. 
Results
Data from 54 studies with 230 729 participants 
were included. The majority of studies 
suggested an association between increasing 
age and prolonged diagnostic interval or 
deferral of a decision to investigate cancer 
symptoms. Thematic synthesis highlighted 
three important factors that resulted in 
uncertainty in decisions involving older adults: 
presence of frailty, comorbidities, and cognitive 
impairment. Data suggested patients wished 
to be involved in decision making, but the 
presence of cognitive impairment and the need 
for additional time within a consultation were 
significant barriers.
Conclusion
This systematic review has highlighted 
uncertainty in the management of older adults 
with cancer symptoms. Patients and their 
family wished to be involved in these decisions. 
Given the uncertainty regarding optimum 
management of this group of patients, a shared 
decision-making approach is important.
Keywords
cancer; decision making, shared; early 
detection of cancer; frail elderly; primary health 
care; systematic review.
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Definition of older adults
There is no universally accepted age 
threshold for defining old age. The World 
Health Organization’s definition of ‘older 
people’ as those aged ≥65 years was 
adopted in this study.14 
Eligibility criteria
Any studies (qualitative and quantitative) of 
patients aged ≥65 years or with a subgroup 
of patients aged ≥65 years with symptoms 
and signs that warrant investigation and 
referral for suspected cancer presenting 
to primary care before diagnosis were 
included. Case–control, cohort, and cross-
sectional studies were included as well 
as interview and focus group studies. 
Editorials, single/clinical case studies, 
reviews, expert opinion articles, and studies 
that were published as abstracts were 
excluded from the review.
Search strategy
On 29 April 2020 electronic databases 
(Box 1) were searched for published and 
unpublished studies of cancer-related 
shared decision making (SDM) for older 
adults in primary care. See Supplementary 
Appendix S1 for full search strategies.
Subject headings and free-text words 
were identified for use in the search 
concepts by the study authors and based on 
the search strategy published in a similar 
review.15 No limits (for example, language 
or date of publication) were applied to the 
search. The searches were peer reviewed 
by a second information specialist. 
Further relevant studies were sought by 
searching the citations of included studies, 
and hand searches of conference abstracts 
(Cancer and Primary Care Research 
International Network, National Cancer 
Research Institute, Macmillan Cancer 
Support, and Cancer Research UK).
Data collection
All titles and abstracts were independently 
reviewed by two authors. Any disagreements 
were resolved through discussion or 
through adjudication by a third author. 
Reasons for exclusion were recorded. Data 
extraction was undertaken using a data 
extraction template. 
Risk of bias of included studies
The mixed-methods appraisal tool (MMAT) 
was used to assess the risk of bias for 
the included studies.16 The reviewers’ 
reasons for ratings, including strengths 
and weaknesses of studies, were recorded 
independently by two authors before 
agreeing on a final score. 
Synthesis of results
Meta-analysis was not possible because 
of the heterogeneity of the included 
studies. Quantitative studies were 
therefore analysed using the SWiM 
(Synthesis Without Meta-analysis) 
reporting guidelines and checklist.17 
Qualitative studies were analysed using 
thematic synthesis described by Thomas 
and Harden.18 Quotes and supporting 
information were extracted using a 
template and imported into NVivo (version 
12). Quotes and text were then coded line by 
line before the development of descriptive 
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How this fits in 
There is uncertainty in the management 
of cancer symptoms in primary care. 
This is the first review, to the authors’ 
knowledge, to consider the effect of older 
age on decision making by patients and 
GPs when patients present to primary 
care with cancer symptoms. Multiple 
factors were found to influence the patient 
and GP decision to investigate cancer 
symptoms including the presence of frailty, 
comorbidities, and cognitive impairment; 
family and carer involvement; and 
consultation time. Given the uncertainty, 
a shared decision-making approach 
is appropriate, but in routine general 
practice this may be difficult to achieve, 
mostly because of a lack of time within the 
consultation.
Box 1. Systematic review search strategy
• Applied Social Sciences Index and Abstracts (ASSIA) (ProQuest) 1987 to present 
• CINAHL (EBSCOhost) 1981 to present 
• Cochrane Central Register of Controlled Trials (Wiley): Issue 4 of 12, April 2020 
• Cochrane Database of Systematic Reviews (Wiley): Issue 4 of 12, April 2020 
• EMBASE Classic+EMBASE (Ovid) 1947 to 27 April 2020  
• Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily 1946 to 
28 April 2020  
• APA PsycINFO (Ovid) 1806 to April Week 3 2020 
• Web of Science Core Collection: Citation Indexes (Clarivate Analytics) 1900 to present 
• ISRCTN registry (Springer) 
• ClinicalTrials.gov (US National Institutes of Health) 
• Evidence Search (National Institute for Health and Care Excellence)
and analytic themes that enabled 
comparisons and synthesis between 
studies. This synthesis was undertaken 
independently by two reviewers. The 
ENTREQ guidelines were followed for 
reporting the synthesis of qualitative 
research.19 Following the separate analysis 
of qualitative and quantitative data, the 
findings were combined by considering 
the barriers and facilitators to decision 
making in primary care. This method was 
based on previous published guidance 
on integrating qualitative research in 
systematic reviews.20
RESULTS
The database searches identified 
5336 studies. After title and abstract 
screening and full-text review, 54 articles 
were included with 230 729 participants 
(Figure 1). Studies ranged in size from 9 
to 109 433 participants. In total, 29 articles 
included quantitative data,11,21–48 24 provided 
qualitative data,49–72 and one included both 
qualitative and quantitative data.48 A variety 
of study settings and cancer types were 
included (see Supplementary Tables S1 
and S2). Overall, the quality of studies was 
judged to be high with an average MMAT 
across the 54 included studies of 4.6/5. 
Quantitative study results
The 29 quantitative studies included in this 
review are summarised in Supplementary 
Table S1. A variety of cancers were 
investigated in a number of different 
countries. The association between 
increasing age and the investigation and 
3  British Journal of General Practice, Online First 2021
Figure 1 PRISMA flow diagram.
Identification of studies via databases and registers
Records identified from:
ASSIA (n = 99)
CINAHL (n = 799)
Cochrane Central Register
 of Controlled Trials (n = 45)
Cochrane Database of
 Systematic Reviews (n = 3)
EMBASE (n = 1703)
MEDLINE (n = 1608)
PsycINFO (n = 233)
Web of Science Core Collection: 
Citation Indexes (n = 478) 
ISCRTN (n = 32)
Clinicaltrials.gov (n = 34)
Evidence Search (n = 302)
Total found in database
search (n = 5336)







Authors contacted — no
response (n = 5) 
Reports excluded:
 Did not include/separate older
     adults (n = 95)
 Did not focus on diagnostic
     decisions (n = 28)
 Did not focus on cancer (n = 24)
 Focus of study was on cancer
     screening (n = 14)
 Study was conducted in
     secondary care (n = 11)
 Focus of study was emergency
     presentation (n = 3)
Reports assessed for
eligibility (n = 47)
Reports sought for retrieval
(n = 47)
Records identified from:
Websites (n = 6)




 Did not include/separate
     older adults (n = 30)
 Did not focus on diagnostic
     decisions (n = 12)
Records screened
(n = 3502)
Reports sought for retrieval
(n = 229)
Reports assessed for
eligibility (n = 224)


















Identification of studies via other methods
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referral of cancer symptoms was not related 
to the type of cancer being investigated or the 
study setting. Outcomes considered by the 
studies included the association between 
increasing age and decision making on 
cancer investigations and referral, and on 
the primary care interval as defined by the 
Aarhus Statement.49 
Fifteen studies considered the length of 
the primary care interval. Seven studies 
reported that age was not associated 
with time to referral or diagnosis,28–34 five 
reported that increasing age was associated 
with a prolonged diagnostic interval,23–27 and 
three reported increasing age resulted in 
shorter diagnostic intervals.21,22,48 
Eleven studies considered the association 
between increasing age and GP factors that 
may affect the decision to investigate cancer 
symptoms. These factors included suspicion 
of cancer, cancer referral, anticipated 
regret (because of missed diagnosis), and 
loss of continuity of care. Two studies found 
that increasing age was associated with 
GP factors that would prompt a decision to 
investigate cancer symptoms.35,36 However, 
five studies suggested that increasing age 
was associated with factors that would 
prevent or delay the investigation of cancer 
symptoms.27,37–40 The remaining four studies 
found that increasing age was not associated 
with GP factors on decisions to investigate 
or refer cancer symptoms.32,41,42,47
Five studies considered the association 
between increasing age and patient aspects 
of the diagnostic process. Two studies 
found that, with increasing age, patient 
factors such as declining investigations 
and not attending appointments were more 
common.11,43 Three studies found that age 
was not associated with patients’ preference 
to proceed with investigations for suspected 
prostate cancer, patients’ wish for cancer 
investigations, or attitudes towards a cancer 
diagnosis.44–46
These results of the quantitative analysis 
are summarised in Figure 2. The qualitative 
results below go some way to explaining 
these findings. 
Qualitative study findings
Twenty-five studies included in the review 
provided qualitative data on the association 
with age and the primary care interval 
(Supplementary Table S2).48,50–73 Thematic 
synthesis identified the following themes 
on the decision to investigate or refer 
cancer symptoms in older adults: the effect 
of old age on GP and patient decision 
making; frailty, cognitive impairment, and 
comorbidities; involving family and carers 
in decision making; and consultation time. 
The difficulty of providing adequate time 
within the primary care consultation for 
older adults was also highlighted.
The effect of old age on GP and patient 
decision making. The included studies 
suggested the presence of significant 
variation in how GPs and patients managed 
cancer symptoms in an ageing population. 
There was evidence that older adults faced 
additional barriers to diagnosis, with cancer 
symptoms sometimes being attributed to 
the ‘effects of old age’ by both patients 
and GPs. Data suggested that GPs could 
make decisions on behalf of patients but 
this may result in depersonalisation and 
a loss of autonomy. One study suggested 
that GPs may apply their own personal 
values to decision making, which could 
be at odds with that of the patient.69 In 
contrast, there was also evidence of doctors 
considering quality of life and life expectancy 
when making decisions rather than age 
alone, which affected the likelihood of 
investigation and referral. These findings 
are summarised in Box 2.
Frailty, cognitive impairment, and 
comorbidities. Frailty, comorbidities, and 
cognitive impairment were highlighted 
as important themes throughout the 
qualitative synthesis, and are summarised 
in Box 3. The study analysis suggested that 
GPs undertook an assessment of a patient’s 
overall health or frailty when making 
decisions about the investigation or referral 
Figure 2. Diagram to show the number of quantitative 
studies, the association with cancer diagnosis, the 
cancer investigated, and the quality assessment. Size 
of circle corresponds to the quality rating judged using 
MMAT.
MMAT = mixed-methods appraisal tool. 
Older age associated
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for cancer symptoms. Older adults deemed 
to be frail or in poor health were less likely to 
be investigated or referred if they developed 
cancer symptoms. However, the evidence 
base behind these assessments of frailty 
were questioned by patients and GPs. There 
was a concern that GPs could overestimate 
frailty, especially with older adults in care 
homes, which could negatively affect 
the investigation and referral for cancer 
symptoms in these patients.
The presence of cognitive impairment 
had a similar effect to that of frailty in the 
study analysis. Some GPs were less likely to 
investigate patients with dementia because 
of the perception that patients with cognitive 
impairment may be distressed by medical 
examinations or investigations and not 
benefit from a diagnosis of cancer. However, 
it was also recognised that patients with 
cognitive impairment may be physically fit 
and have a good quality of life, and as a 
result that it was necessary to ‘continue to 
fight’, as one GP put it.56 The presence of 
cognitive impairment was also identified as 
a barrier to SDM. 
The study analysis suggest that 
comorbidities such as osteoarthritis, 
chronic back pain, chronic obstructive 
pulmonary disease, cerebrovascular 
disease, and anxiety and depression were 
attributed as a cause for symptoms by both 
GPs and patients. This frequently resulted 
in a delay in the investigation or referral 
for cancer symptoms. However, there were 
also examples of cancer symptoms being 
investigated as a result of attending routine 
health checks for comorbidities.
Involving family and carers in decision 
making. As a result of advanced age, 
frailty, or cognitive impairment, there were 
frequent discussions about the impact of a 
patient’s family or carers on the decisions 
made in primary care, especially in patients 
with cognitive impairment (Box 4).
The studies suggested that, if patients 
had advanced cognitive impairment, then 
that patient’s family and carers should be 
involved in decisions on investigation of 
cancer symptoms. However, there was 
concern that the wishes of the family and 
carers may not support those of the patient. 
There were also concern over the level of 
responsibility that should be managed by 
relatives. 
Consultation time. It was recognised by 
both patients and GPs that time constraints 
within the consultation could limit the 
communication of symptoms by patients. 
Although a lack of time in the consultation 
could affect patients of all ages, it was 
more likely to affect older adults because 
of the presence of frailty, comorbidities, and 
cognitive impairment, resulting in more 
complex consultations. 
A study of GPs found that most were 
aware that time constraints within 
consultations with older adults limited 
what could be discussed.60 Two studies 
highlighted problems with policies such as 
‘one appointment, one problem’, which may 
not suit an older patient demographic.74,75 
However, there was evidence that GPs 
considered the practicalities of older 
adults attending appointments, with one 
GP suggesting that older adults may find 
afternoon appointments easier.60 
DISCUSSION
Summary
To the authors’ knowledge, this is the first 
systematic review to explore the effect of 
old age on the investigation and referral 
of cancer in primary care. The majority 
of studies suggest a possible association 
between increased age and a prolonged 
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Box 2. Themes and illustrative quotes demonstrating the effect of 
old age on GP and patient decision making
Theme Subtheme Illustrative quotes
Old age alone can Possible cancer symptoms A GP stated: 
affect decision are attributed to the ageing  ‘I find that there can be a short delay in  
making process management, because we tend to trivialise  
  symptoms that can be attributed to age, fatigue,  
  asthenia, maybe a slight anaemia, things that are  
  relatively trivial. We tend to say it’s just age.’ 56 
  A patient stated:
  ‘It was … a gradual process, which I put down to old  
  age … [and] I’d had a bad back, so I was quite sort of  
  willing to accept that my back hurts a bit.’ 48
 Healthcare professionals ‘With an elderly patient, certain specialists and  
 may make decisions on general practitioners have a tendency to make the  
 behalf of older patients decision on behalf of the patient, which is an  
  important problem.’ 56
 Healthcare professionals’  The carer recalled that the GP stated: 
 personal values may be at  ‘… for what life shall we save him?’  
 odds with those of the  The carer further reported:  
 patient and carers ‘… it was like he didn’t want anything to be done, 
  that there was no point in doing anything, and that 
  we should be satisfied with taking the world 
  as we found it.’ 69
 Old age alone should not A GP stated: 
 delay investigation and  ‘I have folks [in whom] we’re doing certain tests and  
 referral things well beyond what generally is recommended 
  but I think for good reason … I have a couple  
  patients in their late 80s and 90s where I tell them:  
  “you’re likely to live another decade or two … so we  
  might need to be a little more aggressive … ”.’ 71
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diagnostic interval or deferred cancer 
investigations. The findings suggest that, for 
patients and GPs, deciding how to manage 
older patients with symptoms that could 
herald a cancer diagnosis is challenging. 
As well as an assessment of the patient’s 
wishes, such decisions often require an 
assessment of patients’ overall health or 
frailty, along with a judgement as to whether 
the harms of investigation or referral would 
be justified by benefits.
There is significant variation in the findings 
of the studies included in this review. Some 
studies found that older adults and those 
with high levels of frailty or comorbidity 
had prolonged diagnostic intervals or were 
not investigated for possible cancer, which 
were in direct contrast with other studies in 
the same patient group. This variation may 
reflect uncertainty and a lack of evidence 
regarding the management of cancer 
symptoms in older adults. Judgements 
undertaken by GPs based on a patient’s 
Box 3. Themes and illustrative quotes demonstrating the effect of frailty, cognitive impairment, and 
comorbidities
Theme Subtheme Illustrative quotes
Frailty Healthcare professionals are informally assessing A GP stated: 
 frailty ‘I’ve never used any specific scale to assess anyone’s frailty. I don’t know what the evidence is 
  behind that frailty score.’ 50
 Healthcare professionals are less likely to A GP stated: 
 investigate or refer patients they deem to be frail ‘We need to consider … the psychological and organic weaknesses that mean, possibly 
  justifiably, that we shouldn’t do as much as we would with a younger person.’ 56
  A GP stated:
  ‘This woman in her 80s had a breast mass … she [had] poor life expectancy, she was already on 
  home oxygen, heart failure, all those comorbid conditions, we could see her lungs failing, and  
  I don’t think we need to do anything about [the breast mass].’ 71
 Assumptions about frailty may prevent investigation A GP stated: 
  ‘There may be a degree [of] assumption going on “I don’t think Mrs Bloggs is well enough” and  
  I wonder whether there is a better way …’ 50
Cognitive  Healthcare professionals are less likely to A GP stated: 
impairment investigate or refer older patients they deem to be ‘Well, I don’t push the investigation or anything … For me, it’s really a complete hindrance to 
 cognitively impaired send people for investigations to seek out cancerous pathology.’ 56
 Older patients with cognitive impairment may be An older patient with dementia who had undergone tests for colorectal cancer stated: 
 distressed by examinations or investigations ‘That woman who ran around and hurt me. Well, she didn’t know what she were doing.  
  “No!” I kept saying to her. I said “It’s not right!” Two people hit at me.’ 
  The study reported that there were also signs of distress during the interview, ’contorting her  
  face’ and ‘wringing her hands with worry’, which showed the pain and distress of undergoing 
  intimate clinical investigations.63
 The presence of cognitive impairment can affect A 79-year-old with colorectal cancer stated it was his wife who had noticed the patient’s  
 communication with healthcare professionals symptoms:
  ‘I have Alzheimer’s disease and my wife noticed the change in bowel habits. I had no other signs  
  or symptoms.’ 67
 Despite cognitive impairment, patients may be fit A GP stated: 
 and investigation could be warranted ‘Even if they’re very cognitively impaired, we can still share plenty of things, and often they find  
  that it’s worthwhile to continue to fight.’ 56
Comorbidities Investigation and referral of symptoms possibly The carer of a 78-year-old man recalled how the GP attributed his signs of illness to pain from a  
 owing to cancer were delayed because of knee replacement: 
 comorbidities ‘We said, you know, he’s really finding it hard to mobilise and you know, loss of appetite and  
  depression. And, [the GP] instead of looking for another reason, it was, “oh well, he’s in pain.  
  You know, if you sort the pain out, we’ll sort the other bits out”.’ 55
  A 72-year-old woman with ovarian cancer and longstanding back pain reported:
  ‘I first visited my doctor about my symptoms … I was not examined. I was told the pain was  
  coming from my back (I had a back problem for years).’ 67
  ‘I’ve got COPD [chronic obstructive pulmonary disease] but I never coughed up blood before. I  
  thought it will clear up but after two weeks it didn’t so I thought I had better get it checked.’ 53
 Annual check-ups for comorbidities resulted ‘The cancer was only found on annual chest check for COPD.’ 67  
 in opportunities for earlier diagnosis A patient (aged between 85 and 89 years) with lung cancer stated:
  ‘I go six monthly to the nurse in the clinic and I mentioned to her I was spitting blood and she  
  said “well make an appointment with the doctor” …’ 53
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age or perceived frailty could result in 
inconsistency and a high degree of variation 
in clinical practice. However, the variation 
could also be the result of well-balanced 
decisions to postpone investigations 
because of a low likelihood of benefit from 
a cancer diagnosis and a higher risk of 
complications from cancer investigations or 
treatment. Finally, it may be a consequence 
of patient preference in shared decisions 
around investigation.
The review has highlighted both patients’ 
and their families’ wishes to be involved in 
decisions around care. Given the uncertainty 
regarding optimum management of this 
group of patients, an SDM approach is likely 
to be helpful. However, it is not clear how 
best to implement this, and several barriers 
to its use were highlighted in this review, 
most notably the presence of cognitive 
impairment and the need for additional 
time within a consultation to fully inform the 
patient and allow for SDM.
Strengths and limitations
This large systematic review of 54 studies 
has been robustly carried out and 
demonstrates important and novel findings 
for patients and primary care practitioners. 
Studies were included from a variety of 
countries and investigated a wide range of 
cancer types. The heterogeneity of included 
studies precluded meta-analysis and may 
have also resulted in contrasting findings. 
There is inconsistency in the use of terms 
to describe the primary care interval within 
the literature and included studies. This 
was addressed in the current study by 
reviewing the details of each study against 
the inclusion criteria. The MMAT for quality 
assessment was chosen as both qualitative 
and quantitative studies were included; 
however, the tool was found to be limited in 
discriminating study quality. Finally, many 
of the included studies, particularly the 
qualitative ones, included few participants 
and as a result may not be generalisable to 
the older adult population as a whole.
Comparison with existing literature
Although this is the first review, to the 
authors’ knowledge, to consider the effect 
of age on diagnostic decisions, there are 
multiple studies concerning the treatment 
decisions of older adults who are frail and 
have a diagnosis of cancer. These studies 
are largely based in secondary care and have 
other competing factors to consider, such as 
the side effects of potential treatments and 
the chances of success. However, the effect 
of age, frailty, comorbidities, and cognitive 
impairment are frequently highlighted in 
these studies. Overall, the results of this 
review are supported by the findings of work 
undertaken on cancer treatment.
A systematic review on the effect of frailty 
on cancer outcomes found that patients 
with cancer and a diagnosis of frailty had 
increased all-cause mortality, increased 
postoperative mortality, and more frequent 
complications of treatment than patients 
with cancer without a diagnosis of frailty.7 
A review on the impact of comorbidity on 
cancer treatment found similar results. 
The review reports that patients with 
comorbidity had poorer survival, poorer 
quality of life, and higher healthcare 
costs than those without comorbidities.76 
A systematic review on the effect of 
dementia on cancer outcomes found that 
patients with dementia and cancer had 
a reduced likelihood of receiving: cancer 
screening, cancer staging information, 
cancer treatment with curative intent, and 
pain management compared with those 
with cancer only.77 A qualitative study on 
the information needs of patients with 
dementia making decisions about cancer 
treatment found that cancer treatment was 
adjusted because of dementia; that there 
were difficulties in communicating clinical 
information that resulted in the frequent 
involvement of informal caregivers; and 
a need for information on the functional 
impact of dementia and how this will affect 
cancer treatment.78 These studies are 
largely based in secondary care and have 
other competing factors to consider, such as 
the side effects of potential treatments and 
the chances of success. However, the effect 
of age, frailty, comorbidities, and cognitive 
Box 4. Themes and illustrative quotes demonstrating the impact of a 
patient’s family or carers on the decisions made in primary care
Theme Subtheme Illustrative quotes
Family and carers Family and carers should be  A GP stated: 
 involved in decision making  ‘If we’re referring to patients with advanced cognitive  
 in patients with cognitive  impairment … it’s obvious that the decision should be 
 impairment taken with the carers, those close to the patient, their  
  family …’ 56 
 The wishes of family and  A GP stated: 
 carers may be at odds with ‘A 50-year-old who says to you “If I’m ever in that  
 the wishes of the patient position, let me go, don’t insist, let me die or help me 
  to die”, but when they [the family] face that situation
  [later in life], if the smallest door of hope opens, they 
  [the family] take it; it’s normal.’ 56
 What level of responsibility  ‘Uncertainty extended to knowing how much, or how  
 should be taken by the  little, they [the family] were to be involved in the 
 family or carers? clinical investigations consent process of their relative  
  with dementia and what level of responsibility — if any  
  — they shouldered in taking such a decision.’ 63
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impairment are frequently highlighted in 
these studies. Overall, the results of this 
review are supported by the findings of work 
undertaken on cancer treatment.
Implications for research and practice 
National guidelines on investigation 
and referral of patients with cancer 
symptoms do not consider older age or 
frailty.1,79 However, the question of whether 
healthcare professionals should treat older 
adults with cancer symptoms differently 
remains.9 It is not possible to make 
appropriate management decisions on the 
basis of age alone, as many patients remain 
active and healthy well into advanced 
age, or may express preferences about 
investigation and treatment. Even patients 
who may not be able to tolerate aggressive 
cancer treatments might still benefit from 
diagnosis, for example, should they wish to 
know about prognosis or to access palliative 
care. This review highlights uncertainty in 
both patients’ and GPs’ views and decisions 
surrounding the investigation and referral of 
older adults with cancer symptoms. In this 
context of uncertainty, an SDM approach 
is most appropriate.9 This would allow 
patients, and in some cases their family, 
to evaluate the pros and cons of diagnostic 
referral on an individual basis. SDM is a key 
part of the NHS Long Term Plan,80 which 
advocates personalised care across the 
whole care system. 
Barriers to the use of SDM, however, 
were apparent in the review. The authors of 
this current study consider in a primary care 
consultation that there is insufficient time to 
fully undertake SDM, with the presence 
of cognitive impairment, comorbidities, 
and frailty; complex medical/social 
circumstances; the need for assessments 
of capacity; and to involve family members. 
Significant work has been undertaken to 
understand the use of SDM and holistic 
geriatric assessment tools to aid decision 
making for cancer treatment.81 These 
barriers might be addressed by further use 
of pre-diagnostic frailty scoring systems 
and holistic assessments of older adults, 
and may benefit from further development 
of geriatric oncology services expanding 
into primary care, as has been suggested 
in work considering frailty and cancer 
treatment.7
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